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Cystinosis  is  an  autosomal  recessive  disease  causing  intracellular  accumulation  of  cystine
crystals  [1].  Children  involved  by  the  disease  are  born  normal  but  rapidly  develop  end-
stage  renal  failure.  Renal  transplantation  and  cysteamine  (which  converts  cystine  into  a
soluble  form)  have  recently  helped  to  prolong  these  patients’  lives.
Symptomatic  damage  to  the  central  nervous  system  [2]  (cognitive  and  motor  disorders
and  epilepsy)  affects  2%  of  adult  patients  [3]  although  a  few  magnetic  resonance  imag-
ing  (MRI)  observations  have  been  reported.  We  describe  the  case  of  a  patient  suffering
from  encephalopathy  secondary  to  cystinosis  in  whom  encephalic  MRI  showed  perivascular
update  of  contrast  associated  with  micronodular  T2*  hypointensity.
Case report
The  patient  was  being  followed  up  for  childhood  cystinosis  and  had  a  renal  transplant  at
the  age  of  8 years  old.  Adherence  to  cysteamine  treatment  had  always  been  poor  with
intralyzosomal  cystine  measurements  between  2.5  and  6.4  demi-cystine/mg  of  protein
(normal  <  1).  Clinically,  the  patient  had  complications  of  cystinosis  with  eye  damage,  thy-
roid  failure,  anemia,  impairment  of  the  renal  transplant  and  cognitive  disorders  since
adolescence.
∗ Corresponding author.
E-mail address: cazalsxavier@hotmail.com (X. Cazals).
2211-5684/$ — see front matter © 2013 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.
http://dx.doi.org/10.1016/j.diii.2013.03.003
6o
s
a
t
f
c
w
i
w
c
w
o
(
t
p
u
v
n
a
c
t
n
a
t
s
r
t
F
(
D
S
n
b
r
a
l
H
t
a
c
c
i
a
t
h
s
a
i
s
r
y
c
u
i
s
cause  microangiopathy,  which  is  responsible  for  white  mat-
ter  abnormalities  and  can  also  produce  cerebral  atrophy,54  
At  the  age  of  24  years,  the  patient  had  a  transient  episode
f  right  brachial  and  facial  deﬁcit  associated  with  apha-
ia.  MRI  (1.5  T,  GE  Medical  System)  (Fig.  1)  showed  diffuse
trophy  and  multiple  areas  of  ischemic  in  the  semi-oval  cen-
re,  T2  hyperintensity  in  the  periventricular  areas,  a  few
rontal  sub-cortical  T2*  hypointensity  and  slight  uptake  of
ontrast  in  the  perivascular  spaces  in  the  fronto-parietal
hite  matter  and  central  grey  nuclei.  Investigation  of  the
ntracranial  arterial  blood  vessels  was  normal.  The  patient
as  started  on  treatment  with  160  mg  of  lysine  acetylsali-
ylate.
He  gradually  developed  walking  difﬁculties,  together
ith  a  cerebellar  and  frontal  pyramidal  syndrome.  Because
f  clinical  worsening,  a  further  MRI  (3  T,  Siemens  verio)
Fig.  2)  was  performed  3  years  later  and  showed  persis-
ent  T2*  hypointensity  and  increased  contrast  update  in  the
erivascular  stasis  and  T2  hyperintensity  in  the  periventric-
lar  areas.  Investigation  of  the  intracranial  arterial  blood
essels  was  normal  and  the  laboratory  assessment  showed
o  acute  phase  reaction.  Adherence  was  still  poor  with
n  intraleukocyte  cystine  level  raised  at  6.4  nmol  demi-
ystine/mg  of  protein.
In  view  of  the  context  of  poor  adherence  to  treatment,
he  clinical  ﬁndings  compatible  with  complications  of  cysti-
osis  and  the  lack  of  an  acute  phase  reaction,  the  MRI
bnormalities  were  attributed  to  encephalopathy  secondary
o  the  cystinosis.
The  patient  was  already  being  treated  with  immuno-
uppressive  drugs  and  treatment  therefore  consisted  of
ecommending  that  he  improves  his  adherence  to  the  cys-
eamine.
igure 1. Multiple nodular hyperintensities in the white matter (a: wei
b). Periventricular hyperintensity areas on T2 Fluid Attenuated Inversio
a
wX.  Cazals  et  al.
iscussion
ymptomatic  central  nervous  system  damage  due  to  cysti-
osis  is  rare  although  their  incidence  is  liable  to  increase
ecause  of  new  methods  of  management.  Berger  et  al.  [4]
eported  a  patient  suffering  from  cervical  myelitis  associ-
ted  with  internal  capsule  and  hemisphere  T2  hyperintensity
esions,  some  of  which  increased  uptake  after  injection.
istological  analysis  showed  a  perivascular  lymphocyte  inﬁl-
rate  associated  with  a  cystine  crystal  deposition  and  a  small
nd  median  diameter  blood  vessel  vasculitis.  In  our  case,
ontrast  was  taken  up  with  the  perivascular  spaces  located
lose  to  the  areas  of  T2*  hypointensity.  The  main  reasons  for
ncreased  uptake  in  the  perivascular  spaces  are  vasculitis
nd  infectious  inﬂammatory  or  malignant  meningeal  inﬁl-
ration.  In  our  case,  the  areas  of  increased  contrast  may
ave  been  due  to  vasculitic  lesions  in  small  diameter  ves-
els,  secondary  to  cystine  crystals,  which  are  known  to  cause
n  autoimmune  reaction  and  explain  the  deep  infarction
n  the  initial  neurological  episode.  CT  angiography  did  not
how  stenoses  although  this  is  known  to  have  poor  spatial
esolution  distally  [5].  The  main  differential  diagnosis  in
oung  adults  is  granulomatous  diseases  (sarcoidosis,  histio-
ytosis),  although  these  are  associated  with  pachymeningeal
ptake  and/or  uptake  in  the  pituitary  stem.  The  T2*  hyper-
ntensity  areas  could  represent  microhemorrhagic  lesions
econdary  to  small  vessel  damage.  Renal  impairment  canghted diffusion sequences) (white arrows) with restricted diffusion
n Recovery (FLAIR) (black arrows).
lthough  this  has  been  shown  to  be  more  common  in  patients
ith  cystinosis  [2].
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[6] Broyer M, Tete MJ, Guest G, Bertheleme JP, Labrousse F, Pois-Figure 2. MRI performed 3 years later. Hyperintensity areas on 
nodular hyperintensities. T2* hypointensities (b) (arrow) and contras
(d) after gadolinium injection] in the deep white matter and centra
The  treatment  of  cystinosis  encephalopathy  was  cor-
rected  adherence  to  cysteamine  and  immunosuppressant
therapy.  Broyer  et  al.  [6]  have  shown  that  improving  adher-
ence  to  cysteamine  can  stop  progression.
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